Pharma Co. Falsely Touted Obesity Drug Results, Suit Claims

By Sydney Price · May 7, 2024, 10:22 PM EDT

Biopharmaceutical company Altimmune Inc. and three of its executives were hit with a proposed class action alleging they overstated the clinical trial results and prospects of its obesity drug and its...

To view the full article, register now.